Omlonti to reduce intraocular pressure
Drug Name: Omlonti Active Ingredient: oomidenepag isopropyl ophthalmic solution Indications: To reduce elevated intraocular pressure in patients with open‑angle glaucoma or ocular hypertension Approval Date: 9/22/2022 Company: Santen Incorporated…